Welcome to our dedicated page for THERMA BRIGHT ORD news (Ticker: TBRIF), a resource for investors and traders seeking the latest updates and insights on THERMA BRIGHT ORD stock.
Therma Bright Inc. (TBRIF) is a developer and partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies. The company focuses on providing consumers and medical professionals innovative solutions to address today's most important medical challenges. Therma Bright is traded on TSX Venture Exchange (THRM) and OTCQB (TBRIF). Recent achievements include receiving a cease trade order from the Ontario Securities Commission and working diligently to file required documents. Therma Bright also announced the reopening of its application for Venowave device codes and plans for a strategic review to maximize shareholder value.
Therma Bright, a developer of diagnostic and medical device technologies, announces a non-brokered private placement offering up to $1,000,000 by issuing 100,000,000 units at $0.01 per unit. Each unit includes one common share and a half-warrant, with full warrants exercisable over three years at $0.05 in the first year and $0.10 in the subsequent years. The proceeds will fund their Digital Cough technology, pay debts, and support general working capital. The offering is expected to close by June 7, 2024, pending regulatory approvals. Additionally, Therma Bright has granted stock options and warrants to directors, officers, consultants, and entered into debt settlements issuing common shares.
FAQ
What is the current stock price of THERMA BRIGHT ORD (TBRIF)?
What is the market cap of THERMA BRIGHT ORD (TBRIF)?
What is Therma Bright Inc.?
Where is Therma Bright Inc. traded?
What recent achievements has Therma Bright Inc. made?
What strategic initiative is Therma Bright Inc. undertaking?
What is the focus of Therma Bright Inc.'s technologies?
